Upset with Trump’s international pricing index, PhRMA submits a counteroffer: Politico esagonowsky Wed, 08/26/2020 – 09:46

FDA puts India’s Wintac on blast for lackadaisical probe into bacterial contamination kblankenship Wed, 08/26/2020 – 10:58

Liability risks emerge as an obstacle in Europe’s COVID-19 vaccine negotiations: Reuters esagonowsky Wed, 08/26/2020 – 11:17

AbstractObjectiveTo assess the risk of bias associated with missing outcome data in systematic reviews.DesignImputation study.SettingSystematic reviews.Population100 systematic reviews […]

The pandemic arrivesThe covid-19 pandemic has led to unprecedented uncertainty for governments and healthcare bodies across the world, […]

When I sat down to consider the topic for this issue, it was January 2020 and the number […]

Pregnant women were no more likely to suffer severe symptoms of COVID-19 or be ill for longer than […]

In a pivotal Phase II/III study, twice as many patients receiving the drug achieved the primary endpoint of […]

The firms will use Engitix’ extracellular matrix (ECM) discovery platform to develop new therapies for fibrotic liver diseases

Asciminib was superior to bosutinib in inducing a major molecular response